The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Disparities in pre-exposure prophylaxis access and routine screening continue to hinder national efforts to prevent and treat ...
Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated Canadian guideline published in CMAJ (Canadian Medical Association Journal) ...
Now, we have things like pre-exposure prophylaxis (PrEP), approved in 2012 for use among high-risk populations, which was a pill that you could take once a day for the prevention of HIV. (Next), we ...
Maputo – The Ndlavela Health Center, in the municipality of Matola, hosted yesterday the official launch ceremony for the provision of Lenacapavir (LEN) administration services, an alternative drug ...
The guideline, an update to 2017 guidance, was developed through the Canadian Institutes of Health Research (CIHR) Pan-Canadian Network for HIV and STBBI (sexually transmitted and blood-borne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results